Literature DB >> 16569935

Occupational determinants of cryptogenic polyneuropathy.

Martin Tondel1, Jonas Lindh, Pia Jonsson, Magnus Vrethem, Bodil Persson.   

Abstract

OBJECTIVES: The aim was to investigate different occupational and leisure time exposures as determinants for cryptogenic polyneuropathy.
METHODS: A case-referent study was conducted in Sweden including 232 cases of cryptogenic polyneuropathy 40-79 years of age at diagnosis who were enrolled from the out-patient neurology departments of 3 hospitals. From the population register 853 referents were randomly selected. Information on occupational and leisure time exposure was obtained from a postal questionnaire. The response rate was 71% for cases and for referents. Crude odds ratios (CORs) and logistic regression odds ratios (LORs) were calculated for exposures with 5 or more exposed cases and referents taken together. The reference category was defined as individuals unexposed to any of the occupational or leisure time risk factors in the questionnaire.
RESULTS: As expected, male sex and increasing age were significant determinants for cryptogenic polyneuropathy. Occupational exposures in men to Stoddard solvent, petrol exhausts, herbicides or hand and foot vibrations generated significantly increased CORs. LORs >3.50 were found in men for occupational exposure to sulphur dioxide, xylene, methyl ethyl ketone, herbicides and in women for occupational exposure to lead, nitrous oxide and insecticides. Only solvent exposure in leisure time remained significant in the regression analysis indicating that not only occupational exposures were of importance. Interactions between occupational and leisure time exposure were seen for several agents.
CONCLUSIONS: Several known determinants for polyneuropathy, from animal studies and case reports, were confirmed. New determinants were also indicated, i.e. sulphur dioxide, xylene and methyl ethyl ketone. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16569935     DOI: 10.1159/000092405

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  5 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

Review 2.  Chronic idiopathic axonal polyneuropathy: a systematic review.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Channa Hewamadduma; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2016-03-09       Impact factor: 4.849

3.  Guillain-Barré syndrome and postbariatric surgery polyneuropathies.

Authors:  Kanayochukwu J Aluka; Patricia L Turner; Terrence M Fullum
Journal:  JSLS       Date:  2009 Apr-Jun       Impact factor: 2.172

4.  Polymorphisms of GSTT1, GSTM1, and EPHX genotypes in patients with cryptogenic polyneuropathy: a case-control study.

Authors:  Jonas Lindh; Peter Söderkvist; Mats Fredrikson; Shahrzad Hosseininia; Martin Tondel; Bodil Persson; Magnus Vrethem
Journal:  Brain Behav       Date:  2011-11       Impact factor: 2.708

5.  Urinary 2,5-hexanedione excretion in cryptogenic polyneuropathy compared to the general Swedish population.

Authors:  Bodil Persson; Magnus Vrethem; Nicola Murgia; Jonas Lindh; Anna-Lena Hällsten; Mats Fredrikson; Martin Tondel
Journal:  J Occup Med Toxicol       Date:  2013-07-30       Impact factor: 2.646

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.